The Retina Partners are committed to advancing the future of medicine through our work in clinical research. Our physicians and research staff take pride in our involvement in nationwide clinical trials to bring our patients the latest treatment options for a variety of retinal conditions.
We are dedicated to providing the highest quality of care to our patients by offering the opportunity to receive novel treatments that are at the forefront of medicine for retinal diseases.
We believe our contributions to clinical research will help create more treatment options, better outcomes, and an improved quality of life for our patients.
Welcome to the Institutional Biosafety Committee (IBC) Meeting Minutes archive. The IBC is responsible for reviewing research involving recombinant or synthetic nucleic acid molecules and other biohazardous materials to ensure compliance with institutional, federal, and local biosafety regulations.
Below you will find a link to summaries of our committee meetings, including key decisions, protocol reviews, and updates on biosafety practices. These minutes are provided to promote transparency and support our commitment to safe and ethical research.
